Skip to main content
NVNO logo

NVNO · enVVeno Medical Corp

Track NVNO — free
$10.39 -0.09 (-0.86%) At close · Aug 20
Market Cap
$7.15M
Shares
682,722

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.39 Open$10.44 Day$10.17–11.59 Since split$8.67–13.00 Avg vol 30d23K Short int18K · 2.7% float · 1.0d Short vol50% DataJan 2026–Aug 2026 Filing10-Q · Jul 30

Raw chart and full-history price indicators begin at the captured split on Jan 20, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jan 20, 2026.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 30, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −3%
below
RSI (14) 46
neutral
MACD trend Negative
52-week position 40%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Neutral
1-month return +3%
trailing
6-month return 0%
trailing
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.68% of float · ▲ +68.7% MoM · 1.0 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
17 holders — near 3-yr low, contrarian setup
Squeeze score 46
elevated · 0–100
Fundamentals
Strong
Revenue growth −83%
Y/Y
Gross margin 597%
expanding
EPS growth +26%
Y/Y
Free cash flow $-15.6M
Balance sheet $2.8M
net cash
Quant / Vol
risk profile
Very High
Volatility 81%
annualized · 1-yr
Max drawdown −28%
past year
ATR 8.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−3% Neutral
RSI (14)
46 Neutral
MACD trend
Negative Bearish
52-week position
40% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.68% of float · ▲ +68.7% MoM · 1.0 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
17 holders — near 3-yr low, contrarian setup
Price context
position in its range since split · 2026-01-20
Range low $9 Now $10 · 40% Range high $13
vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NVNO
enVVeno Medical Corp
this stock
$7.15M -83.3% 2.7%
ABT
Abbott Laboratories
$198.81B -8.9% +5.7% 32.0 1.3%
SYK
Stryker Corp
$127.26B -6.8% +11.2% 34.4 2.2%
MDT
Medtronic plc
$120.49B -3.9% +8.4% 25.2 1.4%
BSX
Boston Scientific Corp
$71.55B -48.2% +12.5% 20.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
17
% held
13.0%
Net QoQ
-11.8K sh
Top holder
KINGDON CAPITAL MANAGEMEN…
Held Float
View
Held by Funds
Fund positions
7
View
Short & Settlement
Short Interest Rising
Shares short
18.3K
Days to cover
1.0d
Change
+7.4K sh
View
Short Volume
Short vol %
50%
As of
Aug 20, 2026
Short Total
View
Fails to Deliver
FTD shares
2
Value
$21
As of
Jul 1, 2026
View
Off-Exchange
Off-exchange %
74.1%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$31.2K
Net income (FY)
$-19.5M
EPS diluted
$-33.06
View
Filings
SEC Filings
Latest
10-Q
Filed
Jul 30, 2026
This year
7
View
Proposed Sales
Value
$1.4K
Shares
140
Filed
Jun 11, 2026
View
Exempt Offerings
Offering
$1.6M
Filed
Aug 4, 2020
View

Performance

Raw-price comparisons begin at the captured split on Jan 20, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
NVNO -4.3% +2.8% +0.4% -2.0%
SPY -2.0% +3.3% +11.2% +2.1% +11.8%
vs SPY -2.3% -0.5% -10.8% -4.1%
Key facts CIK 1661053 CUSIP 29415J205 13F (30d) 17 filings 17 filers Visit website Investor relations